Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001386060-26-000063·Cytek Biosciences, Inc.
Schedule 13G ownership disclosure
Cytek Biosciences Inc
Common Stock · CUSIP: 23285D109
Event date: 2026-09-30
- Filing-level shares
- 8,002,638
- Percent of class
- 6.16%
- Boston Partners
Shares: 8,002,638 · Class: 6.16%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001386060-26-000063
- Form type
- SCHEDULE 13G/A
- Filer
- Cytek Biosciences, Inc.
- CIK
- CIK 1831915
- Filed
- Nov 13, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership